leflunomide has been researched along with Foot Dermatoses in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Foot Dermatoses: Skin diseases of the foot, general or unspecified.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sardana, K | 1 |
| Gupta, A | 1 |
| Boyd, AS | 1 |
2 other studies available for leflunomide and Foot Dermatoses
| Article | Year |
|---|---|
A recalcitrant case of ulcerative lichen planus responsive to leflunomide.
Topics: Female; Foot Dermatoses; Humans; Immunosuppressive Agents; Leflunomide; Lichen Planus; Middle Aged; | 2020 |
Successful treatment of recalcitrant eczematous dermatitis with leflunomide.
Topics: Eczema; Enzyme Inhibitors; Female; Foot Dermatoses; Hand Dermatoses; Humans; Isoxazoles; Leflunomide | 2013 |